Global Biotechnology

IBISWorld
April 12, 2013
45 Pages - SKU: IBSS5094497
Natural and Organic Foods and Beverages in the U.S., 4th Edition
7/16/2014 | published by: Packaged Facts
Natural and Organic Foods and Beverages in the U.S., 4th Edition U.S. retail sales of natural and organic foods and beverages rose 5.5% to nearly $53.5 billion in  |  read more...
USD 3,995
Proteins in Oncology Drug Pipeline Update 2014
7/15/2014 | published by: BioSeeker Group AB
Proteins in Oncology Drug Pipeline Update 2014 This drug pipeline update covers proteins, excluding antibodies, as drugs for the treatment of cancer. There are today 326 companies plus partners developing 359 protein drugs in 667 developmental projects  |  read more...
USD 6,746
Critical Care Therapeutics in Major Developed Markets to 2020 - New and Late-Stage Four-Factor PCCs and Recombinant Products to Drive Market
7/14/2014 | published by: GBI Research
Critical Care Therapeutics in Major Developed Markets to 2020 - New and Late-Stage Four-Factor PCCs and Recombinant Products to Drive Market Summary GBI Research, the leading business intelligence provider, has released its latest research: “Critical Care Therapeutics  |  read more...
USD 3,500
Advanced Cell Diagnostics, Inc. - Product Pipeline Analysis, 2014 Update
7/15/2014 | published by: GlobalData
Summary Advanced Cell Diagnostics, Inc. (ACD) is a biotechnology company. The company operates in the field of molecular pathology, developing cell and tissue based diagnostic tests for personalized medicine. Its products include RNAscope probes, RNAscope assays,  |  read more...
USD 750
Biocrates Life Sciences AG - Product Pipeline Analysis, 2014 Update
7/15/2014 | published by: GlobalData
Summary Biocrates Life Sciences AG (Biocrates) is a biotechnology company. The company develops metabolomic products and vitro diagnostics (IVDs) for early disease detection. Its metabolomic solutions set a new level of standardized data processing, exchange, and  |  read more...
USD 750
Celera Corporation - Product Pipeline Analysis, 2014 Update
7/15/2014 | published by: GlobalData
Summary Celera Corporation is a diagnostics company. The company develops, manufactures, and commercializes molecular diagnostic products that are used by hospitals and other clinical laboratories to detect, characterize, monitor and select treatment for disease. Its products  |  read more...
USD 750
Exosomics Siena SpA - Product Pipeline Analysis, 2014 Update
7/15/2014 | published by: GlobalData
Summary Exosomics Siena SpA (Exosomics) is a biotechnology company. The company develops and validates proprietary immunometric multiplex assays for non-invasive cancer diagnostics, and monitoring and point of care devices for cancer screening. Its business models include  |  read more...
USD 750
Genomic Health, Inc. (GHDX) - Product Pipeline Analysis, 2014 Update
7/15/2014 | published by: GlobalData
Summary Genomic Health, Inc. (Genomic Health) is a life sciences company. It focuses on the research, development and commercialization of genomic-based clinical laboratory services for the treatment of cancer. The company's commercial product portfolio consists of  |  read more...
USD 750
GlycoZym - Product Pipeline Analysis, 2014 Update
7/15/2014 | published by: GlobalData
Summary Glycozym is a biotechnology company. The company develops HTP platform for production of PTM-peptide microarrays for the analysis of protein interactions affected by posttranslational modifications. Its products include PTM-pepscan, PTM-pepome, PTM-peplibrary, and O-PTM-biomarkers. Glycozym provides  |  read more...
USD 750
IQuum, Inc. - Product Pipeline Analysis, 2014 Update
7/15/2014 | published by: GlobalData
Summary IQuum, Inc. (IQuum) is a biotechnology company. The company conducts biological sample testing through its unique platform and performs multiple biological assays in an insert-and-test format. Its clinical IVD products comprise Liat analyzer, and flu  |  read more...
USD 750
 

SELECT A LICENSE

    Online Download  USD 1,020  
    Global Site License  USD 2,550  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!